CORMEDIX INC. - COMMON STOCK

CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities

21 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

07 Jan 2025 06:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Added to Nasdaq Biotechnology Index

19 Dec 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

26 Nov 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

04 Nov 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

30 Oct 2024 06:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces New Data at ASN Kidney Week 2024

24 Oct 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

23 Oct 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator

08 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces New Commercial Agreement

19 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

13 Sep 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces New Commercial Agreement

09 Sep 2024 09:52:30 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update

14 Aug 2024 06:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

07 Aug 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Outpatient Availability of DefenCath

03 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. Receives FDA Feedback on Potential Label Expansion

18 Jun 2024 07:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

06 Jun 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

10 May 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

09 May 2024 06:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024

06 May 2024 07:30:00 By Nasdaq GlobeNewswire